El Camino Well being announced Tuesday that it will commence applying a new blood flow monitoring technologies known as FloPatch, a wearable ultrasound program that makes it possible for clinicians to extra proficiently treat sufferers with sepsis. The Mountain View-primarily based wellness program is the very first in the globe to adopt the new technologies, according to the announcement.
“Timing is essential when caring for sufferers with sepsis,” Cheryl Reinking, chief nursing officer at El Camino Well being, mentioned in a statement. “Our nurses have noticed firsthand how efficient FloPatch is in monitoring the effectiveness of remedy in deteriorating sufferers, specially these with sepsis and low blood stress.”
In partnership with Flosonics Healthcare, the developer of FloPatch, El Camino Well being has been piloting the FloPatch technologies for the previous year at Fogarty Innovation, the health-related technologies and startup incubator that operates out of El Camino Hospital.
“Our nurses instantly loved it, and helped choose exactly where in the hospital the technologies would be the very best match,” Reinking mentioned.
FloPatch is an FDA-authorized device that delivers rapid and constant measurements to aid clinicians track a patient’s heart function.
“Once placed on a patient’s neck, the FloPatch constantly assesses blood flow in the carotid arteries, which are the big blood vessels that provide blood to the brain, neck, and face,” the statement mentioned. “FloPatch then wirelessly transmits that information to a safe iOS mobile application, giving clinicians with actionable, true time information at the bedside.”
When a patient with sepsis arrives at the hospital, the statement mentioned, the very first important step is to treat them with IV fluids. But it can be difficult to administer the appropriate quantity of fluid, and also a great deal can bring about big complications for sufferers.
“While there are tools presently obtainable that can measure fluid response, they are cumbersome and time-consuming to use,” the statement mentioned. “FloPatch’s sophisticated analytics engine quantifies and displays altering metrics more than the course of an assessment and aids clinicians provide extra precise fluid remedy and eventually, greater care to sufferers.”
El Camino Well being cited a study which located that 4 to 5 sufferers will stay clear of potentially risky fluid overload for each and every ten FloPatch makes use of.
The FloPatch is the most recent technologies to advantage from El Camino Health’s health-related technologies accelerator system out of Fogarty Innovation (FI), a six-month-extended mentoring system that aids early-stage providers develop.
“With guidance from their lead FI mentors, Mike Regan, chief innovation officer, and Dr. Zach Edmonds, strategic advisor, the Flosonics group worked straight with clinicians at El Camino Well being to achieve a greater understanding of the patient journey and ascertain the very best clinical use for their groundbreaking technologies,” the statement mentioned.
